For a publicly traded buyer, Wall Street generally tolerates dilution of the buyer's EPS in an Mergers and Acquisitions deal up to what percentage?

In the context of Mergers and Acquisitions, dilution of earnings per share (EPS) refers to a situation where the buyer's EPS decreases as a result of the acquisition. For publicly traded companies, Wall Street typically allows a certain level of EPS dilution before it becomes a concern regarding the health or attractiveness of the deal.

The level of dilution that is generally tolerated is often around 4%. This threshold is important because it balances the potential benefits of the acquisition—such as synergies, increased market share, or enhanced capabilities—against the immediate impact on shareholder value as measured by EPS. If the dilution is within this 4% range, investors may be more accepting, believing that the long-term benefits will outweigh the short-term impact.

Dilution exceeding this threshold can raise red flags among investors and analysts, potentially indicating that the acquisition might not be strategically sound or beneficial in the long run. Therefore, staying within the 4% tolerance is critical for maintaining investor confidence in a publicly traded buyer's acquisition strategy.